These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 32538071)
21. Epirubicin upregulates UDP glucuronosyltransferase 2B7 expression in liver cancer cells via the p53 pathway. Hu DG; Rogers A; Mackenzie PI Mol Pharmacol; 2014 Jun; 85(6):887-97. PubMed ID: 24682467 [TBL] [Abstract][Full Text] [Related]
22. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients. Djebli N; Picard N; Rérolle JP; Le Meur Y; Marquet P Pharmacogenet Genomics; 2007 May; 17(5):321-30. PubMed ID: 17429314 [TBL] [Abstract][Full Text] [Related]
23. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population. Hwang MS; Lee SJ; Jeong HE; Lee S; Yoo MA; Shin JG Drug Metab Pharmacokinet; 2010; 25(4):398-402. PubMed ID: 20814162 [TBL] [Abstract][Full Text] [Related]
24. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites. Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858 [TBL] [Abstract][Full Text] [Related]
25. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244 [TBL] [Abstract][Full Text] [Related]
26. In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes. Dong D; Zhang T; Lu D; Liu J; Wu B Xenobiotica; 2017 Apr; 47(4):277-283. PubMed ID: 27180825 [TBL] [Abstract][Full Text] [Related]
27. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism. van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546 [TBL] [Abstract][Full Text] [Related]
28. Steviol glucuronidation and its potential interaction with UDP-glucuronosyltransferase 2B7 substrates. Wang M; Lu J; Li J; Qi H; Wang Y; Zhang H Food Chem Toxicol; 2014 Feb; 64():135-43. PubMed ID: 24296138 [TBL] [Abstract][Full Text] [Related]
29. Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation. Rowland A; Gaganis P; Elliot DJ; Mackenzie PI; Knights KM; Miners JO J Pharmacol Exp Ther; 2007 Apr; 321(1):137-47. PubMed ID: 17237258 [TBL] [Abstract][Full Text] [Related]
30. In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats. Wu W; Hu N; Zhang Q; Li Y; Li P; Yan R; Wang Y Chem Biol Interact; 2014 Aug; 219():18-27. PubMed ID: 24854283 [TBL] [Abstract][Full Text] [Related]
31. Identification of cyclosporine A and tacrolimus glucuronidation in human liver and the gastrointestinal tract by a differentially expressed UDP-glucuronosyltransferase: UGT2B7. Strassburg CP; Barut A; Obermayer-Straub P; Li Q; Nguyen N; Tukey RH; Manns MP J Hepatol; 2001 Jun; 34(6):865-72. PubMed ID: 11451170 [TBL] [Abstract][Full Text] [Related]
32. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9. Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745 [TBL] [Abstract][Full Text] [Related]
33. Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapy. Gu Y; Tingle MD; Wilson WR J Pharmacol Exp Ther; 2011 Jun; 337(3):692-702. PubMed ID: 21427202 [TBL] [Abstract][Full Text] [Related]
34. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. King C; Tang W; Ngui J; Tephly T; Braun M Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973 [TBL] [Abstract][Full Text] [Related]
35. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms. Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425 [TBL] [Abstract][Full Text] [Related]
36. The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene promoter. Gregory PA; Gardner-Stephen DA; Rogers A; Michael MZ; Mackenzie PI Pharmacogenet Genomics; 2006 Jul; 16(7):527-36. PubMed ID: 16788384 [TBL] [Abstract][Full Text] [Related]
37. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver. Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626 [TBL] [Abstract][Full Text] [Related]
38. Hepatocyte nuclear factor-1alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers. Toide K; Takahashi Y; Yamazaki H; Terauchi Y; Fujii T; Parkinson A; Kamataki T Drug Metab Dispos; 2002 Jun; 30(6):613-5. PubMed ID: 12019184 [TBL] [Abstract][Full Text] [Related]
39. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol. Chen M; LeDuc B; Kerr S; Howe D; Williams DA Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037 [TBL] [Abstract][Full Text] [Related]
40. Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Girard C; Barbier O; Veilleux G; El-Alfy M; Bélanger A Endocrinology; 2003 Jun; 144(6):2659-68. PubMed ID: 12746330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]